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Characterizing the tissue-specific binding sites of transcription factors (TFs) is essential to 
reconstruct gene regulatory networks and predict functions for non-coding genetic variation. 
DNase-seq footprinting enables the prediction of genome-wide binding sites for hundreds of TFs 
simultaneously. Despite the public availability of high-quality DNase-seq data from hundreds of 
samples, a comprehensive, up-to-date resource for the locations of genomic footprints is lacking. 
Here, we develop a scalable footprinting workflow using two state-of-the-art algorithms: 
Wellington and HINT. We apply our workflow to detect footprints in 192 ENCODE DNase-seq 
experiments and predict the genomic occupancy of 1,515 human TFs in 27 human tissues. We 
validate that these footprints overlap true-positive TF binding sites from ChIP-seq. We 
demonstrate that the locations, depth, and tissue specificity of footprints predict effects of genetic 
variants on gene expression and capture a substantial proportion of genetic risk for complex traits.
Graphical Abstract
In Brief
DNase-seq footprinting provides a means to predict genome-wide binding sites for hundreds of 
transcription factors (TFs) simultaneously. Funk et al. analyze data from the ENCODE consortium 
to create a resource of footprints in 27 human tissues, demonstrating associations of tissue-specific 
TF occupancy with gene regulation and disease risk.
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Regulation of gene expression by transcription factors (TFs) forms the basis for tissue- and 
cell-type differentiation arising from complex interplay between the TFs and the chromatin 
architecture in gene regulatory regions (Neph et al., 2012a; Tewhey et al., 2016). In humans, 
genetic perturbation of TF binding sites is thought to be an important mechanism by which 
single-nucleotide polymorphisms (SNPs) influence risk for human disease (ENCODE 
Project Consortium, 2012; Gusev et al., 2014; Maurano et al., 2012). Thus, characterizing 
the cell-type-specific occupancy of TFs at their genomic binding sites is a critical goal in 
genomics, providing insight into networks of TFs and their cell-type-specific target genes, as 
well as causal mechanisms underlying risk for human disease (Ament et al., 2018; 
Claussnitzer et al., 2015; Gupta et al., 2017; Moyerbrailean et al., 2016; Pearl et al., 2019).
Mapping human gene regulation requires comprehensive resources of tissue- and cell-type-
specific TF binding sites. Major efforts over the past decade have produced vast quantities of 
public epigenomic data that have dramatically expanded the functional annotation of the 
human genome (Encode Project Consortium, 2004; Battle et al., 2017; Ward and Kellis, 
2016), yet our understanding of cell-type-specific TF binding sites remains far from 
complete. Annotation of TF binding sites based solely on the locations of sequence motifs is 
imprecise because only ~1% of motif instances are occupied by a TF at any given time 
(Neph et al., 2012a). Similarly, information about the locations of promoters and enhancers 
lacks sufficient specificity because many genetic variants in these regions do not affect gene 
expression (Tewhey et al., 2016). TF occupancy can be ascertained with high sensitivity and 
specificity through chromatin immunoprecipitation followed by deep sequencing (ChIP-
seq), in which an antibody specific to a TF is used to pull down genomic DNA fragments 
occupied by that TF in a given sample. However, high-quality ChIP-seq data have been 
generated for only a minority of all human TFs and often used standard cell lines rather than 
disease-relevant human tissues.
Genomic footprinting is a higher-throughput approach that predicts TF genomic occupancy 
by combining information from open chromatin assays (such as DNase sequencing [DNase-
seq]) with information about the locations of sequence motifs recognized by the DNA 
binding domains of TFs. DNase-seq assays are predicated on accessibility of genomic DNA 
to DNase I, where regions of open chromatin are susceptible to cleavage by DNase I. 
Binding of TFs and other DNA binding proteins can lead to a relative difference in the 
number of cleavage events in discrete regions along the genome, resulting in a footprint 
(Galas and Schmitz, 1978). Computational algorithms have been developed to identify 
footprints from high-throughput DNase hypersensitivity (DHS) data, typically using one of 
two strategies: (1) sliding window approaches in which the relative number of DNase 
cleavage events are counted along a sliding window of the genome, agnostic to the absence 
or presence of a TF binding motif (Boyle et al., 2011; Gusmao et al., 2014; Neph et al., 
2012b; Piper et al., 2013; Sung et al., 2014) and (2) approaches that begin with the known 
location for a TF binding motif and model the DNase cleavage patterns around it for all sites 
in the genome (Cuellar-Partidaet al., 2012; Kähärä and Lähdesmäki, 2015; Pique-Regi et al., 
2011; Sherwood et al., 2014; Yardımcı et al., 2014). Validation of these approaches typically 
has involved comparison of the footprints for individual TFs to binding sites found by ChIP-
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seq. Notably, the computational identification of footprints from high-throughput data 
remains an area of active research, because existing algorithms detect genomic occupancy 
for only a subset of TFs. Moreover, because of redundancy in the sequence specificity of 
TFs, footprinting generally cannot distinguish which member of a TF family is occupying a 
footprint. Nonetheless, the accuracy and reproducibility of TF binding site predictions from 
footprinting analysis has begun to rival that of ChIP-seq, and DNase-seq footprinting has 
successfully been used to predict the binding sites for hundreds of TFs in a parallel 
approach.
One of the most important applications of comprehensive atlases of TF binding sites will be 
to functionally annotate genetic risk variants for human diseases. Many studies have shown 
that disease-associated SNPs are enriched in gene regulatory regions, including open 
chromatin regions identified through DNase-seq and ATAC-seq experiments (de la Torre-
Ubieta et al., 2018; Finucane et al., 2015; Gusev et al., 2014; Maurano et al., 2012). 
However, genome-wide association study (GWAS) risk loci are defined by large sets of 
genetically correlated SNPs with similarly strong statistical associations to disease, of which 
only a subset are thought to be functional and causal for disease risk. It remains 
controversial how many of these causal SNPs disrupt gene regulation by altering the specific 
base pairs occupied by TFs versus other mechanisms. Several studies have identified risk 
loci for traits such as obesity and schizophrenia in which causal variants appear to 
functionally alter binding sites for key TFs (Claussnitzer et al., 2015; Gupta et al., 2017; 
Pearl et al., 2019). However, other studies question the generalizability of this insight and 
indicate that TF binding sites in existing databases do not fully predict causal variants 
(Moyerbrailean et al., 2016). One explanation for this discrepancy is that existing TF 
binding site databases do not include sufficient amounts of epigenomic data from disease-
relevant tissues. Because the gene regulatory consequences of non-coding SNPs are likely to 
vary dramatically across tissues and cell types (Claussnitzer et al., 2015; Fairfax et al., 
2014), these existing databases may miss context-specific effects of variants on TF 
occupancy. In addition, there is considerable variability in the sensitivity and specificity of 
footprinting algorithms, and it is unclear which approaches will be best suited for this task.
Here, we developed a comprehensive resource of genomic footprints across 27 human 
tissues, using data from 192 DNase-seq experiments from the Encyclopedia of DNA 
Elements (ENCODE). Before our work, there was no publicly available, scalable workflow 
using these data for the purpose of producing footprints. These analyses revealed an 
expansive landscape of tissue-specific genomic occupancy for 1,530 TFs. We validated our 
database based on ChIP-seq and expression quantitative trait loci (eQTLs), and we 
demonstrated that tissue-specific footprints are strongly and specifically enriched for 
disease-associated genetic variation. We have made our footprint database and the 
underlying cloud-based computational workflow available in a user-friendly and intuitive 
format (links available in STAR Methods) (Madduri et al., 2019).
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A Comprehensive Atlas of Genomic Footprints across Human Tissues
ENCODE-generated DNase-seq FASTQ files from 192 experiments in 27 tissues were 
downloaded from the ENCODE data portal (https://www.encodeproject.org/). The tissue-
specific genomic occupancy of 1,515 TFs was then predicted through genomic footprinting 
analyses using the workflow pictured in Figure 1A and detailed in STAR Methods. First, 
sequence reads were aligned to GRCh38 using SNAP (Zaharia et al., 2011). Because the 
DNase-seq data consist of short reads, we generated two alignments: one using the default 
20 bp seed length (Seed20) and another using a 16 bp seed length (Seed16). We then 
identified regions of open chromatin in each of the 192 experiments using F-seq, followed 
by detection of footprints using both HINT and Wellington algorithms. Footprints detected 
in each of the 192 experiments were then grouped by tissue, producing 27 tissue-specific 
footprint maps, with separate maps for each seed size and footprinting algorithm. In general, 
seed size had only a modest impact. ~70% of the footprints had complete overlap between 
the two seed sizes (Figure S1A). In addition, we observed only a moderate relationship 
between the number of footprints found in a sample and the depth of sequencing (Figure 
S1B). Overall, HINT identified more footprints than Wellington.
Footprints from HINT and Wellington are identified without consideration of underlying 
motif sequence. Therefore, to predict which TFs occupy each footprint, we used Find 
Individual Motif Occurrences (FIMO) to create a catalog of all genome-wide instances of 
1,530 sequence motifs recognized by 1,515 TFs (Grant et al., 2011). In addition to the motif-
TF mappings provided by the aforementioned databases, we expanded the motif-TF 
mappings to incorporate families of TFs with similar DNA sequence specificity, using 
information from TFClass (Wingender et al., 2015) (Tables S1 and S2; Figure S2). This 
resulted in ~1.34 billion sequence-to-TF matches (p < 10−4) before intersection with 
footprints, spanning almost 80% of the genome. These motif instances were then intersected 
with the footprints from Wellington and HINT to produce an atlas of predicted TF 
occupancy in each tissue.
When considering all samples from all tissues, the most liberal thresholds resulted in 34% 
coverage of the genome being represented in the atlas for at least one tissue. The brain had 
the highest genome coverage at 14.9%, followed by skin (9.8%) and lymphoblast (8.9%). 
Urinary bladder had the lowest percentage of coverage at 1.1% (Figure 1B). Sample size and 
sequencing depth were the main determinants for the number of tissue-specific footprints 
identified in our atlas. However, intrinsic biological differences in tissue complexity also 
influence the number of distinct footprint locations. For example, we found strong overlap in 
footprint locations across the 46 experiments from skin (average pairwise Jaccard similarity 
index = 0.28), consistent with skin being a relatively homogeneous tissue. By contrast, the 
footprints detected in the 29 experiments from brain were less homogeneous (average 
pairwise Jaccard similarity score = 0.16), which likely reflects the highly specialized and 
disparate cell types and cell-type-specific gene regulation across brain regions. As a 
consequence, we identified more brain footprints than skin footprints, despite having 50% 
more skin samples.
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An outstanding question is to what extent additional samples would add previously unseen 
footprints. To address this, using footprints derived from the HINT algorithm with seed 
length 20 (HINT20), we ordered the brain samples from most to fewest footprints and 
calculated the additional percentage of the genome covered by each sample (Figure 1C). The 
first sample contributed 3.25 million footprints spanning 1.75% of the genome, whereas the 
last sample added 235,000 novel footprints and 0.04% novel genome coverage. We repeated 
the same analysis using only high-quality footprints based on HINT and Wellington scores 
(see the next section). As expected, this analysis revealed even greater overlap across 
samples, because many footprints detected in only a single sample are of low quality (Figure 
1C, bottom). These results suggest that at least for well-sampled tissues such as brain, our 
atlas captures most detectable footprints.
Validation and Filtering of Footprints with ChIP-Seq and Machine Learning
Next, we sought to validate TF binding site predictions in our atlas and chose appropriate 
thresholds at which footprints reliably indicate TF occupancy. For this purpose, we 
compared footprints from 21 DNase-seq experiments in lymphocytes to predicted TF 
binding sites (peak regions) from ChIP-seq of 66 TFs in the same cell type. The genomic 
background for this analysis is the set of all genome-wide instances of the sequence motifs 
recognized by a given TF. On their own, these motif instances have an extremely high false-
positive rate > 90%. We used the footprints from all 21 samples to define two scores at each 
genomic location: (1) the best footprint score, defined as the highest score at this location in 
any samples, and (2) the footprint fraction, defined as the proportion of independent samples 
with a non-zero footprint score. We then tested for a linear relationship between these 
footprint scores and the likelihood that a motif instance corresponded to a true-positive 
binding site from ChIP-seq, testing performance via the Matthews correlation coefficient 
(MCC), area under the receiver operator curve (AUROC), and area under the precision-recall 
curve (AUPR). The most accurate predictor was the best HINT20 score, which achieved a 
maximum MCC of 0.42, corresponding to AUROC > 0.9 (Figure 2). The high AUROC was 
driven by true negatives, which comprise 3,936,242 of the 4,110,504 total observations. 
Most true negatives had low HINT scores. True positives often had a high HINT score, but 
high HINT scores also had a significant false-positive rate (Figure S3). True and false 
positive here are soft assignments, because ChIP-seq experiments are imperfect predictors of 
TF occupancy.
We were curious whether performance could be improved by combining footprint scores 
from multiple algorithms with additional information about genomic context. We employed 
a supervised machine-learning approach, treating the ChIP-seq peaks as true positives. We 
employed two machine-learning algorithms: linear regression and gradient boosting trees 
implemented with XGBoost. We constructed and evaluated a comprehensive model that 
included as predictors the footprint scores from both HINT and Wellington using both the 16 
bp and 20 bp seed sizes. Additional predictors included a score for the strength of the match 
to the sequence motif, TF class, guanine-cytosine (GC) content, and distance to a 
transcription start site (TSS). We compared this comprehensive model to predictions based 
on footprint scores alone, as well as to a baseline model that considered motif scores and 
genomic context but ignored footprinting data.
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In the comprehensive model, gradient boosting and linear regression achieved maximum 
MCCs of 0.42 and 0.40, respectively (Figure 2), The predictor with the largest contribution 
to accuracy was the best HINT20 score, followed by the HINT20 footprint fraction (Figure 
3). Prediction accuracy was lower in the baseline models but remained better than chance 
(gradient boosting, MCC = 0.32; linear regression, MCC = 0.27) (Figure 2). In these models, 
distance to the TSS was the most significant contributor to the prediction. Although the 
maximum MCCs of the HINT20 footprint-only versus comprehensive models were identical 
(0.42), the footprint-only model had a relatively small threshold window within which both 
true-positive and false-negative error rates were well controlled. Therefore, incorporating 
information about genomic context does not dramatically improve prediction accuracy but 
could potentially improve the robustness of these predictions.
We used machine-learning models to select appropriate cutoffs for high-quality footprints. 
We determined that a HINT score > 200 and a Wellington score < −27 were optimal filtering 
thresholds to control both false-positive and false-negative errors. Applying these filters 
reduced the percentage of coverage of the genome from 34% to 9.8% across all tissues 
(Figure 1B). This filtered estimate is in line with current estimates for the fraction of the 
genome that is actively involved in gene regulation. HINT20 footprints with scores > 200 
were used in downstream analyses unless otherwise specified.
Footprints Predict Effects of Genetic Variants on Gene Expression
An important goal for footprinting is to predict the gene regulatory effects of non-coding 
SNPs. It has previously been shown that most haplotypes with cis-acting effects on gene 
expression (eQTLs) contain SNPs that are located within DNase I hypersensitive regions 
(Handel et al., 2017). However, DHS regions span a large fraction of the genome, and many 
SNPs within DHS regions have no evidence for influencing gene expression. It remains 
controversial whether footprints more precisely capture the causal variants on eQTL 
haplotypes: some recent studies found that only a small fraction of eQTL haplotypes overlap 
footprints (Handel et al., 2017; Moyerbrailean et al., 2016), whereas others have suggested 
stronger enrichment (Degner et al., 2012; Schwessinger et al., 2017). To address this 
question, we examined overlap between footprints in our database with eQTLs from the 
Genotype-Tissue Expression (GTEx) consortium.
We evaluated overlap between footprints (HINT20 score ≥ 200) from our database with 
eQTLs in 44 tissues from GTEx (v.V6p) (Battle et al., 2017). We focused on 1,561,655 
genetic variants significantly associated with the expression of a nearby gene (<1 MB) and 
in the 95% credible set for that gene in at least one tissue, based on Bayesian fine mapping 
with CAVIAR (Hormozdiari et al., 2014); i.e., the set of variants with 95% likelihood to 
contain the causal eSNPs for the gene. Across all eQTL and footprint tissues, we found that 
163,330 of these 1,561,655 variants intersected a TF binding site from our footprint database 
(TFBS-eQTLs). Counts of TFBS-eQTLs in individual tissues from our footprint database 
ranged from 743 (urinary bladder) to 71,692 (extra-embryonic structure) (Figure 4A). We 
tested whether this overlap was greater than expected by chance by mapping footprints to all 
11,959,406 genotyped and imputed variants in the GTEx V6p dataset, followed by 
resampling permutations. We found significant enrichments (p < 0.001) for all 27 footprint 
Funk et al. Page 7













tissue × 44 eQTL tissue combinations. The overlap of footprints and eQTLs in mismatched 
tissues likely reflects that many of the strongest footprints and eQTLs are detected in 
multiple tissues (Battle et al., 2017). Sample size differs dramatically between tissues both in 
our footprint database and in GTEx, making it difficult to discern biologically relevant 
tissue-specific effects. Therefore, in subsequent analyses, we considered all eQTLs together, 
regardless of the tissue in which they were discovered.
We also determined whether eQTL SNPs with the highest likelihood of being causal variants 
from linkage-disequilibrium (LD)-based fine mapping with CAVIAR were also the most 
likely to overlap a footprint. eQTL variants that overlapped a footprint had higher posterior 
probabilities for being causal than eQTL variants that did not overlap footprints (t = −61.4, p 
<< 1e–308). Indeed, we detected a strong positive association between a variant’s posterior 
probability of being causal and the strength of enrichment for footprints that was consistent 
across footprints from all 27 tissues (Figure 4B). Focusing on the 3,193 eQTL variants with 
posterior probabilities > 0.8, we found that 29.2% (932) overlap a footprint. Resampling 
permutations indicated that this overlap for tissue-specific footprints is ~10- to 40-fold 
greater than expected by chance. These results suggest that a large fraction of eQTLs may be 
explained by causal variants that alter TF binding sites, with many of these effects captured 
by footprints in our database.
Tissue-Specific Footprints Are Enriched for Disease-Associated SNPs
Finally, we tested the hypothesis that high-scoring footprints are enriched for genetic 
variants associated with disease risk. To address this question, we studied genome-wide 
summary statistics from well-powered GWAS of eight immune-related traits and 27 
psychiatric, behavioral, and cognitive traits (STAR Methods; Table S3). We hypothesized 
that heritability for immune traits would be specifically associated with footprints in 
lymphocytes, whereas heritability for neuropsychiatric traits would be specifically 
associated with footprints in the brain.
When considering all tissue-specific footprints from our database (HINT20 score > 0 in any 
sample), we found that footprints from brain tissue were strongly enriched for heritability 
for brain-related traits and footprints from lymphoblasts were strongly enriched for 
heritability for immune-related traits. However, because most base pairs that are open 
chromatin have a non-zero footprint score, this result is not distinguishable from previously 
reported enrichments of heritability in open chromatin. We therefore examined whether 
footprints with higher scores contributed more to heritability than footprints with lower 
scores. We used a partitioned heritability approach in which we divided footprints into 
deciles based on their maximum tissue-specific footprint scores. We found that footprints 
with the highest scores in brain contributed disproportionately to heritability to brain-related 
traits but were not strongly associated with immune traits (Figure 5A). Conversely, 
footprints with the highest scores in lymphoblasts contributed disproportionately and 
specifically to heritability in immune-related traits (Figure 5B). Interestingly, we also found 
that positions of open chromatin in the brain that had low footprint scores (bottom decile) 
contributed disproportionately to risk for brain-related traits. Motif enrichment analyses of 
the top versus bottom deciles indicated that these segments of open chromatin are enriched 
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for binding sites for distinct families of TFs. For instance, motifs recognized by several 
neurodevelopmental TFs (e.g., the LMX family) were disproportionately found in the 
bottom decile; these neurodevelopmental TFs are known to bind DNA more transiently than 
other TF classes, leaving a less distinct footprint signature (Baek et al., 2017) (Table S4). 
Altogether, our results support the hypothesis that the enrichment of disease risk in open 
chromatin disproportionately results from variants that affect TF binding and indicate that a 
footprint’s score is positively associated with disease risk for many TFs.
DISCUSSION
Here, we have described a uniform workflow for DNase genomic footprinting and generated 
a comprehensive atlas of TF binding sites in 27 human tissues. We validated these footprints 
using data from ChIP-seq and eQTL experiments. At optimal thresholds, footprints in our 
database span 9.8% of the human genome, describing an expansive landscape of tissue-
specific TF occupancy. We found strong, tissue-specific enrichments of footprints for 
disease-associated SNPs from GWAS, demonstrating the utility of our database to 
characterize gene regulatory mechanisms underlying human disease.
Machine-learning approaches yielded several insights. First, footprinting information 
improved predictive accuracy compared with a baseline model. Because ChIP-seq is an 
imperfect gold standard, some footprints with no corresponding ChIP-seq may nonetheless 
be true binding sites for a TF. Footprinting may identify a broader range of putative binding 
regions relevant to gene regulation, particularly in light of the strong relationship found with 
eQTLs. As a future direction, integration of additional epigenomic data could provide 
additional predictive power to discern active versus inactive binding sites.
We also demonstrated strong enrichments of heritability for complex traits at the highest-
scoring footprints, specifically in disease-relevant tissues. Given that most risk variants in 
GWAS fall within non-coding regions, this finding suggests that disruption of TF binding 
may be a common mechanism by which genetic risk is conferred. These results build on 
previous findings that heritability for complex traits is enriched in open chromatin regions. 
Annotating risk variants with footprint scores improves specificity and mechanistic insight 
compared with annotating these SNPs based only on chromatin state. This finding 
demonstrates the utility of our footprint atlas for fine mapping and other systems-level 
interrogations of complex genetic traits. We found that low-scoring footprints in the brain 
were highly associated with risk and that these footprints disproportionately contained 
motifs for developmental TFs. This indicates that caution should be taken when using hard 
footprint score cutoffs, especially in the brain.
This resource also represents a case study in the development of scalable cloud-based 
systems for large-scale data analysis (Madduri et al., 2019). The Globus Genomics workflow 
used to create this resource can readily be extended to new open chromatin datasets and 
footprinting algorithms as they become available, potentially including newly developed 
approaches for open chromatin profiling in thousands of single cells. This workflow is part 
of a family of interconnected tools being built within our Big Data for Discovery Science 
(BDDS) center (http://bd2k.ini.usc.edu). We have made user-friendly fiat files for all 
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Lead Contact—Further information and requests for resources and reagents should be 
directed to and will be fulfilled by the Lead Contact, Seth Ament 
(SAment@som.umaryland.edu).
Materials Availability—This study did not generate new unique reagents.
Data and Code Availability—Footprint data files are freely available at http://
data.nemoarchive.org/other/grant/sament/sament/footprint_atlas. Code and workflows 
available at https://github.com/globusgenomics/genomics-footprint.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
This study did not use experimental models.
METHOD DETAILS
Overview—We created and executed footprinting workflows using various tools and 
services built and operated as a part of the NIH Big Data to Knowledge (BD2K) Big Data 
for Discovery Science (BDDS) center (http://bd2k.ini.usc.edu). At a high level, these tools 
enabled authoring and orchestration of complex and multi-tool workflows, transparent and 
elastic scaling on cloud resources, reproducible analysis based on provenance captured using 
minids and Big Data Bags (BDBags) (detailed below). The scalable workflows were built 
using the cloud-based Globus Genomics service (Madduri et al., 2014). These workflows 
include data retrieval from ENCODE using our ENCODE2Bag service that creates a 
portable data unit that encapsulates the entire results of an ENCODE query at a specific 
point in time. The resulting BDBag is passed as input to various analysis workflows that are 
executed in parallel to identify DNA footprints using cloud-based resources. The Globus 
Genomics platform, coupled with the BDDS tools, facilitates reproducibility of complex 
analysis for large cohorts through well-defined and published workflows (Madduri et al., 
2019).
BDBags, Minids—The input data from ENCODE consisted of all available DNase 
Hypersensitivity (DHS) datasets from 27 tissue types. ENCODE provides metadata for each 
tissue type which was exported and included in a BDBag (Chard et al., 2016, IEEE Big 
Data, conference presentation). BDBag is a format for defining a dataset and its contents by 
enumerating the data elements, regardless of their location, and for associating metadata. 
BDBags can be passed between services and materialized (by downloading data elements) 
only when needed. All datasets used in the workflow are identified using minids–a 
lightweight identifier for uniquely identifying a dataset. Minid and BDBag tools provide 
mechanisms for exchanging datasets by name, without regard for location or size, and with 
assurance that the data have not been modified.
Funk et al. Page 10













ENCODE2Bag Service and Globus Genomics—The ENCODE2Bag service provides 
a simple web interface for exporting identified, verifiable collections of data from ENCODE. 
The service when given an ENCODE query, dynamically creates a BDBag that is stored on 
Amazon S3, and identified with a minid. The BDBag does not contain the large genomics 
files, but rather includes a manifest file which enumerates the files with their location(s) and 
checksum(s) for verifying integrity when accessed. The summary of the ENCODE query, 
represented as a Tab Separated Value file, is included in the BDBag as metadata to track and 
record provenance. Thus, given a BDBag, a user may, at any point in the future, obtain the 
results of that ENCODE query executed at the original time–an important property for 
reproducibility. BDBag tools abstracts the process by which a BDBag is “materialized.”
Globus Genomics is a cloud-hosted web service that enables rapid analysis of large 
genomics data. The service has over 3000 computationally optimized tools and a collection 
of best practices analysis workflows. Additionally, we added the data management tools 
built as part of the BDDS BD2K center to the service to make it easier for researchers to 
build high performance, reproducible bioinformatics workflows.
Globus provides reliable, secure, and high performance data transfer between Globus 
“endpoints” (Chard et al., 2014). Globus provides a common interface to a variety of storage 
systems ranging from local POSIX file systems, through to cloud object stores (e.g., 
AmazonS3), high performance file systems, and even archival tape storage. Globus is able to 
orchestrate data transfer between any two systems by managing authentication with both 
endpoints, optimizing transfer configurations for transfer rate, recovering from errors, and 
notifying users of transfer status. We used Globus file transfer functionality to move large 
amounts of data from repositories, institutional storage systems, and local computers to the 
high performance, cloud-hosted compute resources used by the workflow.
The analysis workflows require only the minid of the input dataset to perform the analysis. 
The Globus Genomics service uses minid tools to transparently resolve the location of the 
BDBag, it then uses the BDBag tools to identify the contents of the dataset, and finally uses 
Globus to transfer the raw files to the cloud-hosted analysis infrastructure.
Scalable workflow for predicting Transcription Factor Binding Sites—In this 
workflow, we used the above-mentioned tools to materialize the BDBag for each tissue. 
Each tissue type contained DHS data for multiple samples. In addition, each sample had a 
variable number of replicate sequence data. Footprints were generated for the same input 
data using two alignment seed-lengths of 16 and 20 units, respectively. The analysis of the 
data consisted of aligning each replicate sample using the SNAP-aligner (Zaharia et al., 
2011). Once the alignment BAM files were produced for each replicate, they were merged 
using Samtools (Li et al., 2009). The merged BAM file was used to generate regions of open 
chromatin using F-Seq (Boyle et al., 2011) based on the recommended parameters by Koohy 
et al. (2014), with the minimum reported size reduced from 500 bases to 400. Wellington 
was run with the -fdrlimit set to −1, to be the most lenient in reporting. HINT was run using 
standard settings. Neither Wellington nor HINT were run using any cleavage bias correction 
(Gusmaoet al., 2014; Piper et al., 2013). The footprints were then stored in a relational 
database for ease of query.
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The size of the input data (2.5 TB) and variability in replicate quantity for all samples (1591 
FASTQ samples) made for a complex analysis (Figure 1). The Globus Genomics platform 
allowed us to automate this analysis through its support for transparent batch submission and 
parallelization methods. We utilized Amazon EC2 r3.8xlarge instance type with 32 CPUs 
and 244 gigabyte memory per node. The analysis of all tissues generated over 5 TB of data 
while using approximately 68,771 CPU hours (2149.1 node hours). The analysis of each 
tissue was executed in parallel. In addition, each patient and their replicates were executed in 
parallel, as well as each footprint algorithm
Alignment—For each tissue type, we started with the FASTQ files from the ENCODE 
portal (encodeproject.org). Some ENCODE experiments contain multiple biological 
samples, while others may contain only a single sample. An ENCODE experiment may 
contain single or paired-end reads, with varying depth of sequencing and varying read length 
in each experiment.
The ENCODE data was generated using short reads (< 50 bases), resulting in a high number 
of potential sequence matches. This led us to produce alignments based on two different 
hash table seed lengths. Each FASTQ file (or paired-end files) was aligned to GRCh38 using 
the SNAP algorithm (Zaharia et al., 2011). SNAP uses a default seed length of 20. We 
additionally aligned to seed size 16, given the shorter sequence lengths. Using the 
experiment groupings from ENCODE, we produced 386 BAM files for each seed.
Identifying regions of open chromatin—Based on work from Koohy et al. (2014), 
who compared four different approaches (F-Seq, Hotspot, MACS and ZINBA) we used F-
seq (Boyle et al., 2008) to identify regions of open chromatin from the aligned BAM files 
using the same recommended parameters. As stated in the F-Seq documentation, the results 
are non-deterministic because it uses a variable seed number in selecting a starting point for 
determining regions of open chromatin. The seed sets the sliding frame at which regions are 
considered, leading to slightly different beginning and ending points of open-chromatin. The 
resulting regions (in BED format) vary slightly when repeated. The variable coverage on the 
edges becomes less of an issue with increased sample numbers.
Motif database curation—As footprints from HINT and Wellington are motif agnostic 
and do not include information on motif matches, we integrated the footprint locations with 
motifs and motif-transcription factor mappings from JASPAR, HOCOMOCO, UniPROBE, 
and SwissRegulon. There is considerable redundancy between these databases, which often 
contain position weight matrices that are similar or identical. A motif in one database can 
also be quite different from the motif in another database associated with the same 
transcription factor, resulting in different mappings. To avoid inclusion of redundant motifs, 
we updated and modified an existing R package, MotifDB (Shannon and Richards, 2017), to 
include the latest versions of all four databases. We evaluated the similarity of all motifs 
using Tomtom (Gupta et al., 2007). Those motifs that were significantly different from the 
2016 release of JASPAR (-log(p value) ≥ 7.3) were retained, yielding a total of 1,530 motifs. 
In addition to the mappings provided by each of the aforementioned databases, we also 
expanded the TF-motif mappings to incorporate families of TFs with very similar DNA 
sequence specificity, using information from TFClass (Wingender et al., 2015). The 
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complete mapping can be accessed through MotifDB by calling the 
“associateTranscriptionFactors” method. The number of original motifs considered for each 
database and the number of motifs and transcription factor mappings retained after filtering 
are found in Table S1.
Collectively, our aggregated collection of motif databases and mappings contains 1,530 
unique motifs recognized by 1,515 transcription factors. Many motifs were associated with a 
single transcription factor, while a few promiscuous motifs were associated with as many as 
60 transcription factors. Two representative examples of these mappings are found in Figure 
S2. An entire map of all motifs and TFs can be found in the Table S2. Reversing the 
association, many transcription factors were associated with one motif, while a few 
transcription factors were associated with > 100 motifs. The total number of motif-
transcription factor mappings considered was 13,242.
Combining footprints with database of motifs—To maximize coverage, and because 
of the potential imprecise nature of footprints, if any part of a known motif overlapped with 
a single base of the footprint, an entry was created. Intersection was done by porting the 
motif instances and footprints into the GenomicRanges R package, using the “any” option.
ChIP-seq validation and machine learning models—We joined all footprints based 
upon location in the genome to create one unified dataset per tissue. To account for the fact 
that the same footprints are often found in multiple samples from the same tissue, we 
retained the best score for each method and added as an additional metric the number of 
times a footprint was found at that location. As HINT is far more sensitive than Wellington, 
we scaled this count metric to one that captured the fraction of samples in which a given 
footprint was found. After we summed the number of footprints for each location, we used 
the highest number of occurrences as the denominator for all footprints in that method, 
resulting in a fractional representation for the occurrence metric. Additionally, we 
recognized that footprint-motif intersections include overlap of any size, but regions with 
higher overlap might indicate higher-confidence cases. To capture this effect, we calculated 
the overlap distance between each motif and its footprints for both seed as a fraction of motif 
length. JASPAR transcription factor class information was one-hot encoded in our feature 
matrix. GC content was calculated for each motif found within a footprint by using a 
window of 100 bases from the center on each side of the motif. Distance in base pairs (BP) 
to the nearest transcription start site (TSS) was calculated for each motif and transformed 
using the arcsinh (hyperbolic arcsine) function.
For purposes of validating the model, we designated chromosomes 2 and 4 as a hold-out set 
that was left untouched until the very end after all model parameter sets had been tested. 
Chromosomes 1, 3, and 5 were used to test the models as different parameters in 
architectures were explored. The remaining chromosomes were used to train the models. We 
trained two classes of models: 1) a basic logistic regression model, and 2) a gradient boosted 
model, which aggregates an ensemble of decision trees to learn a nonlinear decision 
boundary. Regression models were constructed for their ease of interpretability, as well as 
for a baseline to which we compare the performance of the boosted models. We trained 
logistic regression models not only for all features in the ensemble, but on each feature 
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individually, in order to get an idea of which features were most predictive of ChIP-seq hits. 
The boosted model was chosen based on its predictive power, as gradient boosted trees have 
been shown to offer state of the art performance for tasks of this nature (Olson et al., 2018). 
We used the R package XGBoost to create this model using a maximum tree depth of 7, 200 
rounds of boosting, and a logistic regression optimization criterion (Chen and Guestrin, 
2016).
One challenge that we encountered in creating this model is that the number of footprints for 
a given motif (or set of motifs connected to a given transcription factor) is orders of 
magnitude larger than the number of ChIP-seq peaks. This imbalance is problematic in the 
setting of this machine-learning format, as it increases memory requirements significantly 
and results in a poor signal-to-noise ratio. In order to address this issue in our training set, 
we sampled 20 million hits of 264 motifs, combined these motif hits with our lymphoblast 
footprints, then filtered for a 10:1 ratio of negative-to-positives. We did not filter any of the 
ChIP-seq hits in our training set. This resulted in a more balanced training set in which the 
features associated with true positives could be better learned. We also used a statistical 
measure of performance, the Matthews Correlation Coefficient (MCC), that was designed to 
be robust to unbalanced sample sizes in the two classes being compared (Boughorbel et al., 
2017).
eQTL Enrichment—Expression quantitative trait loci (eQTLs) from the Genotype Tissue 
Expression Consortium (GTEx; V6p 95% credible causal sets) (Battle et al., 2017) were 
downloaded from the UCSC Genome Browser (http://hgdownload.soe.ucsc.edu/goldenPath/
hg19/database) on January 5, 2018. In addition, as a background set, we downloaded the 
table of all 11,959,406 genotyped and imputed variants from the GTEx V6p dataset 
(“GTEx_Analysis_2015-01-12_OMNI_2.5M_5M_450Indiv_chr1-22-
X_genot_imput_info04_maf01_HWEp1E6_variant_id_lookup.txt.gz”) from the GTEx web 
portal (https://www.gtexportal.org/home/; accessed March 16, 2018). GTEx variants were 
converted to hg38 coordinates using the UCSC Genome Browser’s liftOver tool (https://
genome.ucsc.edu/cgi-bin/hgLiftOver) with default parameters. We identified TF binding 
site-altering variants by intersecting the locations of GTEx variants with the locations of TF 
binding sites from DNase-seq footprinting, using the genomic coordinates of motifs that 
overlap a footprint with a HINT score > = 200. Statistical associations between footprints 
and eQTL posterior probabilities were calculated using the t.test() function in R. Statistical 
significance for overlap between variants that alter TF binding sites and variants that are 
eQTLs was calculated from 1,000 re-sampling permutations, drawing variants at random 
from the complete set of genetic variants in GTEx V6p.
Partitioned Heritability Analysis—We utilized a partitioned heritability approach to 
characterize the relationship between footprint confidence scores and relevant phenotypes. 
First, we divided all the pooled footprints in a given tissue type into decile bins based on the 
score assigned to the best HINT20 score (1 = lowest scores, 10 = highest scores). We then 
used portioned LD Score Regression (LDSC) (Finucane et al., 2015) to assess each decile’s 
contribution to heritability for several disease traits. The immune traits assessed were 
ulcerative colitis, type 1 diabetes, rheumatoid arthritis, primary biliary cirrhosis, multiple 
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sclerosis, lupus, Crohn’s disease, and celiac disease. The neuropsychiatric traits included 
educational attainment, neuroticism, schizophrenia, and bipolar disorder, as well as 23 
additional brain-related traits taken from the top 100 most heritable traits in the UK Biobank 
(Table S3) (Bentham et al., 2015; Bradfield et al., 2011; Schizophrenia Working Group of 
the Psychiatric Genomics Consortium, 2014; Cordell et al., 2015; Dubois et al., 2010; 
Psychiatric GWAS Consortium Bipolar Disorder Working Group, 2011; Jostins et al., 2012; 
Okada et al., 2014; Okbay et al., 2016; Sawcer et al., 2011). The top and bottom brain 
deciles were compared using a chi-square test, and we used the residuals to determine over- 
and under-represented TFs in both deciles.
QUANTIFICATION AND STATISTICAL ANALYSIS
DNase-I genomic footprints were identified with HINT and Wellington. Thresholds for 
selecting high-quality footprints were evaluated via a gradient boosting model, comparing 
footprint locations to true-positive TF binding sites from ChIP-seq. Overlap of footprints 
with eQTLs was evaluated with bootstrap permutations and t tests. Enrichment of footprints 
for SNPs associated with risk for human traits was calculated with stratified LD score 
regression. Details are provided in the Method Details section, above.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Comprehensive map of TF occupancy in human tissues from DNase-seq 
footprints
• Footprints contain genetic variants associated with changes in gene 
expression
• Tissue-specific associations of footprints with genetic risk for complex traits
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Figure 1. Footprint Atlas Workflow and Coverage Statistics
(A) Footprints workflow overview. Each tissue type can have multiple quantities of patients 
and replicates. Each replicate is aligned using SNAP-aligner. All replicates for each patient 
are merged using Samtools. Finally, footprints for each BAM file are produced using 
Wellington and HINT and stored in a database.
(B) Percentage of the genome covered by the footprints for each tissue type and all tissues. 
Yellow is without filtering, and dark blue is filtering with HINT score > 200 and Wellington 
score < −27 (each method has its own scale and distribution).
(C) Footprints from the brain for HINT20 are ordered based on the number of footprints and 
summed. The light blue graphs represent the total number of footprints in each sample (top 
is without filtering on score; bottom is filtered as in B). The dark blue line represents the 
cumulative percentage of the genome covered.
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Figure 2. Predictive Performance on a Held-Out Test Set of a Gradient-Boosted Decision Tree 
(GBDT) Model of the 62 TFs (264 Motifs) in the ENCODE-Generated ChIP-Seq Samples
We compare with baseline models that use only motif information, TSS distance, and GC 
content and to a linear model that uses all of these.
(A) Results using motifs devoid of footprint scores and metrics but including the following 
features: GC content, motif score, distance to TSS, and TF classes.
(B) Results for footprints generated from both Seed16 and Seed20 alignments using all 
aforementioned features, footprint scores, and footprint metrics. The GBDT model obtains 
the best performance by nearly all metrics, though the amount by which it outperforms the 
linear model on the footprint data is in some cases marginal enough that an interpretable 
linear model may be preferred for some applications.
The threshold in the third column refers to the decision boundary at which the continuous 
output of the models, which varies between zero and one, is thresholded and a classification 
decision is made. The aggregate models obtain good performance over a relatively wide 
range of thresholds compared with the models using individual methods.
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Figure 3. Importance Matrix Quantifying the Contribution of Each Feature when Trained and 
Tested on the ENCODE ChIP-Seq Dataset for 62 TFs
Funk et al. Page 23













Figure 4. Footprints Overlap with Genetic Variants that Affect Gene Expression
(A) Counts of eSNPs overlapping predicted TF binding sites across all DHS tissues. 
Barplots indicate the total number of eSNPs overlapping footprints across all GTEx tissues.
(B) Comparison of CAVIAR eQTL scores with the fold enrichment for TFBS-eQTLs.
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Figure 5. Partitioned Heritability of Tissue-Specific Footprints in Related GWAS by Footprint 
Confidence Score Decile
(A) Partitioned heritability of brain footprints by decile in 27 summarized brain-related 
traits. Box plots indicate the median and interquartile range of −log10 (p values ) across the 
27 traits.
(B) Heritability of lymphoblast footprint deciles in 8 summarized immune-related traits. 
Decile 1, lowest scores; decile 10, highest scores.
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Footprint BED files This paper http://data.nemoarchive.org/other/grant/sament/sament/footprint_atlas/bed/
Footprint extended TSV 
files
This paper http://data.nemoarchive.org/other/grant/sament/sament/footprint_atlas/extended/
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Celiac GWAS Dubois et al., 2010 https://data.broadinstitute.org/alkesgroup/sumstats_formatted/
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Software and Algorithms
SNAP Zaharia et al., 2011 http://snap.cs.berkeley.edu/
Samtools Li et al., 2009 http://samtools.sourceforge.net/
F-Seq Boyle et al., 2008 http://fureylab.web.unc.edu/software/fseq/
FIMO Grant et al., 2011 http://meme-suite.org/doc/download.html
HINT Gusmao et al., 2014 http://www.regulatory-genomics.org/hint/introduction/
Wellington Piper et al., 2013 https://pythonhosted.org/pyDNase/
Tomtom Gupta et al., 2007 http://meme-suite.org/doc/download.html

















GenomicRanges Lawrence et al., 2013 https://bioconductor.org/packages/release/bioc/html/GenomicRanges.html
XGBoost Chen and Guestrin, 2016 https://xgboost.readthedocs.io/en/latest/
LiftOver Hinrichs et al., 2006 https://genome-store.ucsc.edu
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